36 citations
,
August 2011 in “Journal of Controlled Release”
This review explores the potential of using genetically-manipulated stem cells as both therapeutic agents and gene delivery vehicles for enhanced wound regeneration, but it reports no new clinical results.
This review discusses the progress and challenges in delivering CRISPR/Cas9 systems for in vivo genome editing, highlighting current methods and opportunities for future therapeutic applications.
There have been no new effective hair loss treatments since finasteride, despite technological advancements. Current treatments include finasteride, minoxidil, and RU58841, with ongoing challenges and potential future solutions in research.
A peptide-based hair loss treatment, PP405, reportedly increased hair density by 62% in 90 days, but these claims are unverified and met with skepticism. Users compared PP405 to Minoxidil and Finasteride, expressing doubts about its effectiveness without more evidence.
Korean minoxidil is preferred over Foligain due to its non-greasy, fast-drying formula that lacks propylene glycol, making it more pleasant to use. The user has been using minoxidil for over two years and finasteride for about ten months, but it's unclear how much the Korean minoxidil has contributed to their results.